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Objective: Respiratory manipulations are a mainstay of therapy for infants with 
a univentricular heart, but until recently little experimental information has 
been available to guide their use. We used an animal model of a univentricular 
heart to characterize the physiologic effects of a number of commonly used 
ventilatory treatments, including altering inspired oxygen tension, adding 
positive end-expiratory pressure, andadding supplemental carbon dioxide to 
the ventilator circuit. Results: Lowering inspired oxygen tension decreased the 
ratio of pulmonary to systemic flow. This ratio was 1.29 - 0.08 at an inspired 
oxygen tension of 100%, 0.61 -+ 0.09 at an inspired oxygen tension of 21%, and 
0.42 - 0.09 at an inspired oxygen tension of 15% (p < 0.05 compared with an 
inspired oxygen tension of 100% and a positive nd-expiratory pressure of 0 cm 
H20). High-concentration supplemental carbon dioxide (carbon dioxide ten- 
sion of 80 to 90 mm Hg) added to the ventilator circuit decreased inspired 
oxygen tension from 1.29 -+ 0.11 to 0.42 -+ 0.12 (p < 0.05 compared with 
baseline). A mixture of 95% oxygen and 5% carbon dioxide (carbon dioxide 
tension of 50 to 60 mm Hg) did not decrease the pulmonary/systemic flow ratio 
significantly. All three types of interventions influenced systemic oxygen 
delivery, which was a function of the pulmonary/systemic flow ratio. As the 
pulmonary/systemic flow ratio decreased from initially high levels (greater 
than 1), oxygen delivery first increased and reached an optimum at a flow ratio 
slightly less than 1. As the pulmonary/systemic flow ratio decreased further, 
below 0.7, oxygen delivery decreased. The ability of systemic arterial and 
venous oxygen saturations to predict the pulmonary/systemic flow ratio was 
examined. Venous oxygen saturation correlated well with both pulmonary/ 
systemic flow ratio and systemic oxygen delivery, whereas arterial oxygen 
saturation did not accurately predict either pulmonary/systemic flow rat oor 
oxygen delivery. Conclusion: This model demonstrated the value of estimating 
the pulmonary/systemic flow ratio before initiating therapy. When the initial 
ratio was greater than about 0.7, interventions that decreased the ratio 
increased oxygen delivery and were beneficial. When the initial pulmonary/ 
systemic flow ratio was below 0.7, interventions that decreased the ratio 
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decreased oxygen delivery and were detrimental. We conclude by presenting 
a framework to guide therapy based on the combination of arterial and 
venous oxygen saturations and the estimate of the pulmonary/systemic flow 
ratio that they provide. (J Thorac Cardiovasc Surg 1996;112:644-54) 
T he univentricular heart complexes, including the hypoplastic left heart syndrome, are common con- 
genital heart defects and are the most common cardiac 
cause of neonatal mortality in the first week of life) 
Death from cardiac failure ensues in essentially all 
untreated infants. 2 Management options have been 
described that range from observation without inter- 
vention to surgical palliation with or without cardiac 
transplantation)' 4 Surgical palliation results in a uni- 
ventricular outflow that is divided between the pulmo- 
nary and systemic circulations. Early survival after 
palliation appears to be crucially dependent on the 
balance of pulmonary and systemic flows (Qp/Qs) 
between these two circulations. 5 Anatomic and physi- 
ologic situations that result in an equal distribution of 
cardiac output to the two circulations appear to meet 
with better clinical results. 6The balance of pulmonary 
and systemic flow (Qp/Qs) is delicate and easily per- 
turbed, both by subtle physiologic alterations and by 
therapeutic maneuvers such as changing inspired oxy- 
gen tension (Fio2) or adding an inotropic agent] 
Current knowledge regarding the control of the 
pulmonary and systemic irculations is largely em- 
piric and derived from clinical experience. To more 
thoroughly characterize the effects of therapeutic 
maneuvers on these flows, we developed an animal 
model of the univentricular heart. 8This preparation 
was constructed without cardiopulmonary bypass: 
first an innominate-pulmonary artery shunt was 
placed, and then a nonrestrictive atrial septostomy 
was formed. The tricuspid valve was then rendered 
incompetent. Occluding the right ventricular out- 
flow then functionally removed the right ventricle 
from the circulation. 
For our first protocol using this new model, we 
examined the manner in which changing ventilatory 
mechanics can balance the Qp/Qs ratio. Although 
diligent manipulation of the respirator is a corner- 
stone of medical treatment of patients with a uni- 
ventricular heart, there has previously been little 
experimental data to guide therapy. 9 Changes made 
in inspired oxygen concentration, addition of sup- 
plemental carbon dioxide to the inspired gas mix- 
ture, and positive end-expiratory pressure (PEEP) 
can all have effects on pulmonary vascular esistance 
and may therefore alter pulmonary flow and the 
Qp/Qs ratio. 1° Our first series of experiments was an 
attempt o more accurately define the physiologic 
consequences of these interventions. 
Methods 
Animals. Neonatal pigs (n = 6), 1 to 2 weeks old and 
weighing 3.5 to 6.0 kg, were used. The initial hematocrit 
value in these animals was 26% _+ 4.5%. Animals were 
examined uring the operation to rule out a patent ductus 
arteriosus. All animals were cared for in accordance with 
the "Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
Publication No. 86-23, revised 1985). Additionally, all 
aspects of animal care were in accordance with the 
standards of the Institutional Animal Care and Use 
Committee of the University of Louisville. 
Procedure. Each piglet was anesthetized with ketamine 
(30 mg/kg intravenously) and acepromazine (2 mg/kg 
intravenously) and was intubated. The animals were ven- 
tilated on a VIP Bird pediatric ventilator (Bird Products 
Corp., Palm Springs, Calif.), with initial settings of Fio2 
100% and PEEP 0 cm H20. The initial respiratory rate 
was set at 20 breaths/rain, and tidal volume was set at 15 
to 20 ml/kg. Rate and tidal volume were adjusted to keep 
carbon dioxide tension between 35 to 45 mm Hg. Anes- 
thesia was maintained with pentobarbital (5 mg/kg per 
hour intravenously). 
Both groins were dissected, and systemic arterial blood 
pressure was monitored with a 5F Mikro-Tip catheter 
(MiIlar Instruments, Inc., Houston, Tex.) placed into the 
descending thoracic aorta via the femoral artery. The 
other femoral artery was cannulated to obtain arterial 
blood gases. A fluid-filled catheter was placed into the 
midportion of the inferior vena cava via the femoral vein 
to monitor central venous pressure. The rate of intrave- 
nous fluid administration was adjusted to keep the central 
venous pressure between 7and 10 mm Hg throughout the 
experiment. 
With the animal in the supine position, a median 
sternotomy was performed. The pericardium was tacked 
up to form a well. Heparin (1000 units) was given intra- 
venously, and a 6 mm reinforced polytetrafluoroethylene 
graft* was placed from the innominate artery to the 
common trunk of the pulmonary artery. This was anasto- 
mosed end to end to the innominate artery and end to side 
to the pulmonary artery. 
After the graft was completed, transit ime flow probes 
(Triton, Inc., San Diego, Calif.) were placed on the 
*Gore-Tex vascular graft, registered trademark ofW. L. Gore & 
Associates, Inc., Newark, Del. 
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Fig. 1. The completed animal model. Flow probes are 
depicted about the graft and the aorta. The tricuspid 
valvotomy and the atrial septal defect are not depicted. 
proximal aorta, to measure left ventricular outflow, and 
around the innominate artery just proximal to the graft, to 
measure graft flow. A 5F Mikro-Tip catheter was passed 
from the infundibular portion of the right ventricle into 
the common trunk of the pulmonary artery to monitor 
pulmonary artery pressure. 
A 4F Rashkind septostomy catheter (Bard Inc., Bil- 
lerica, Mass.) was then passed transvenously via the 
remaining femoral vein to create an atrial septal defect. 
The tip of the catheter was guided manually across the 
interatrial septum into the left atrium. The catheter 
balloon was then inflated with 1.5 ml of saline solution and 
the catheter was pulled back into the right atrium, estab- 
lishing a wide communication between the atria. 
The Rashkind catheter was then advanced into the right 
ventricle. The balloon was inflated and the catheter was 
slowly withdrawn, thereby snaring the chordae tendineae 
of the tricuspid valve. By repeated tearing of the chordae 
tendineae, the tricuspid valve could be rendered incom- 
petent. 
Occluding the right ventricular outflow tract completed 
the univentricular circuit. All systemic venous return was 
routed across the atrial septal defect into the left atrium. 
Pulmonary flow was maintained by that portion of the left 
ventricular outflow that exited the innominate artery and 
traversed the polytetrafluoroethylene graft to the pulmo- 
nary artery. Right ventricular distention was prevented by 
having rendered the tricuspid valve incompetent. The 
completed operative preparation is depicted in Fig. 1. 
All pressure measurements were displayed on a 
Hewlett-Packard monitor (Hewlett-Packard Company, 
Andover, Mass.) and simultaneously recorded on a Gould 
recorder (model TA-11, Gould, Inc., Valley View, Ohio). 
Aortic and graft flows were also recorded on the Gould 
recorder. Arterial blood gases were measured on a blood 
and electrolyte analyzer (Stat 5, Nova Biomedical, Nor- 
wood, Mass.). Venous oxygen saturations (Svoa) were 
measured with an oximetric atheter (Opticath, Abbott 
Laboratories, North Chicago, Ill.) placed in the mid- 
abdominal inferior vena cava and were continuously re- 
corded on an Abbott Laboratories recorder. This catheter 
was calibrated with venous blood samples withdrawn from 
the inferior vena cava and analyzed on the Nova blood gas 
analyzer. 
Protocol. After completing the operative preparation, 
we examined the influence of Fio;, PEEP, and supple- 
mental carbon dioxide added to the ventilatory circuit on 
the Qp/Qs ratio. The animal's chest was closed during all 
ventilator manipulations. 
The first set of interventions examined the effects of Fio 2. 
Holding PEEP constant at 0 cm H20, we set the Fio 2 at 
100%, 75%, 50%, and 21%. By adding supplemental nitro- 
gen to the ventilator circuit, we lowered the Fio 2 to 15%. In 
each animal we varied the order of interventions. 
We examined the actions of PEEP at two levels of Fio 2. 
In four piglets, with Fio 2 set at 100%, we varied PEEP to 
0, 5, 10, and 15 cm HaO. In a second set of four piglets, 
with Fio 2 set at 21%, PEEP was set at 0, 7.5, and 15 cm 
HaO. Again, the order of interventions was varied among 
animals. Each animal's chest was closed during all venti- 
lator manipulations. 
In the final set of interventions, supplemental carbon 
dioxide was added to the breathing circuit. Measurements 
were first made at settings of Fio 2 100% and PEEP 0 cm. 
Two concentrations of carbon dioxide were used. Ninety- 
five percent carbon dioxide (high concentration) was 
added into the circuit at a rate of 2 to 4 cubic feet per hour 
with Fio 2 100% and PEEP 0 cm. This concentration a d 
rate were used to obtain an arterial carbon dioxide tension 
(Paco2) of 80 to 95 mm Hg (mean 87 _+ 6 mm Hg) and a 
pH of 6.83 _+ 0.12. Respiratory rate and tidal volume were 
not altered during this intervention. A lower concentra- 
tion of a mixture of 5% carbon dioxide and 21% oxygen, 
similar to that used clinically, was then added to the circuit 
and observations were repeated. The lower concentration 
of administered carbon dioxide resulted in a Paco 2 of 50 
to 60 mm Hg (mean = 56 -+ 3 mm Hg) and a pH of 
6.99 -+ 0.11. 
Data analysis and statistics. Pulmonary and aortic flow 
were measured irectly. Systemic flow was calculated as 
aortic flow minus pulmonary flow, as all pulmonary flow 
was derived from the innominate artery via the innomi- 
nate artery-pulmonary rtery graft. The Qp/Qs ratio was 
then determined by dividing pulmonary flow by systemic 
flow. Pulmonary vascular esistance was determined as 
(MPA - CVP)/Qp, where MPA = mean pulmonary 
artery pressure, CVP = central venous pressure, and 
Qp = pulmonary flow. Systemic vascular esistance was 
defined as (MAP - CVP)/Qs, where MAP = mean 
arterial pressure, CVP = central venous pressure, and 
Qs = systemic flow (calculated from directly measured 
values). Systemic arterial oxygen content was calculated as 
(1.38 × hemoglobin/dl × systemic arterial oxygen satura- 
tion) + (0.0031 × partial pressure of arterial oxygen) and 
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Fig. 2. Relation of Fio 2 and the Qp/Qs ratio, systemic vascular and pulmonary vascular esistance (SVR 
and PVR), and oxygen delivery. Upper panel: As Fio 2 is decreased the Qp/Qs ratio decreases. Middlepaneb 
Systemic vascular resistance is unchanged by changes in Fi02, while pulmonary vascular resistance increases 
when Fio 2 decreases to 50% or less. Lowerpanek Oxygen delivery is maximal for Fi02 50%. This Fio 2 is 
associated with a Qp/Qs of 0.7. *p < 0.05 compared with baseline or maximal value in lower panel. 
oxygen delivery was calculated as systemic arterial con- 
tent × systemic arterial flow. 
A one-way analysis of variance was used to analyze the 
relationship between Fio 2 and Qp/Qs, Fio 2 and pulmo- 
nary and systemic vascular esistance, and Fi02 and oxy- 
gen delivery. One-way analysis of variance was also used 
to analyze the relationship of PEEP and these variables. 
Linear regression analysis was used to determine the 
correlation between arterial oxygen saturation (Sao2) and 
oxygen delivery and Sv% and oxygen delivery. 
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Fig. 3. Influence of the Qp/Qs ratio on oxygen delivery. Oxygen delivery is at a maximum for a Qp/Qs ratio 
of about 0.7, and it decreases when the Qp/Qs ratio either increases or decreases from this range. *p < 0.05 
compared with maximal value for oxygen delivery. 
Results 
At baseline conditions of Fio2 100% and PEEP 
0 cm HzO, mean aortic flow in all animals was 
1270 + 118 ml/min, systemic flow was 569 _+ 68 
ml/min, and mean pulmonary (graft) flow was 700 
_+ 52 ml/min. Mean aortic pressure was 38 -+ 4 
mm Hg and mean pulmonary artery pressure was 
21 _+ 3 mm Hg. The Qp/Qs ratio for individual 
animals ranged from 0.94 to 1.71, with a mean of 
1.29 _+ 0.08. 
Effect of Fio 2. Fig. 2 shows the influence of Fio 2 
on the Qp/Qs ratio, pulmonary and systemic vascu- 
lar resistances, and oxygen availability. As seen in 
the top panel, as Fio 2 was lowered, the Qp/Qs ratio 
decreased, going from 1.29 _+ 0.08 for Fio 2 100% to 
0.42 _+ 0.09 for Fio2 15% (p < 0.05). 
The decrease in the Qp/Qs ratio appeared to be 
related to the actions of lower Fio 2 on pulmonary 
vascular resistance. As een in the middle panel, 
pulmonary vascular resistance increased at Fio 2 
21% and 15%, going from a baseline of 131 _+ 11 
dyne.sec/cm at Fio 2 100% to 412 + 13 
dyne-sec/cm at Fio 2 15% Co < 0.05). Although 
systemic vascular resistance appeared to decrease 
somewhat as Fio2 was lowered, these changes were 
not statistically significant. 
By measuring Sao 2 and Svo2, we were able to 
determine the influence of Fio 2 on systemic oxygen 
delivery. Oxygen delivery initially increased as Fio2 
was decreased, and then declined rapidly as Fio 2 was 
decreased further, with a significant difference be- 
tween ma_~nal oxygen delivery (seen with Fio 2 50%) 
and the minimum (seen with Fio 2 15%, p < 0.05). 
Fig. 3 depicts the relationship of oxygen delivery 
to the Qp/Qs ratio. Oxygen delivery was at a maxi- 
mum at a Qp/Qs ratio of approximately 0.7. Thus 
decreasing Fio z from 100% to 50%, by shifting the 
Qp/Qs ratio to 0.71, optimized oxygen delivery. As 
decreasing Fio2 further lowered the Qp/Qs ratio 
below 0.7, oxygen delivery fell. 
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We also examined the ability of Sao 2 and SVO 2 
to predict the Qp/Qs ratio. Fig. 4 shows a plot of 
Sao 2 and Svo 2 versus a range of Qp/Qs ratios 
generated by varying Fio 2. Both Sao 2 and Svo 2 
form curves, but Sao 2 plateaus for a Qp/Qs 
greater than 1, whereas Svo 2 declines for a Qp/Qs 
greater than 1. It can be seen that the curve for 
Svo2 closely approximates that for oxygen delivery 
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(Fig. 3), with both curves having optimums at a 
Qp/Qs ratio of about 0.7. 
Effects of PEEP. We examined the actions of 
PEEP at two different levels of Fio2--100% and 
21%. Fig. 5 shows the effect of PEEP on the Qp/Qs 
ratio and pulmonary and systemic vascular resis- 
tances for the two groups. The upper panel demon- 
strates that at an Fio 2 of 100%, increasing PEEP 
lowered the Qp/Qs ratio. A similar trend was seen 
for an Fio 2 of 21%. Although the baseline Qp/Qs 
ratio was lower with an Fio 2 of 21%, addition of 
PEEP was able to lower the Qp/Qs ratio further, 
suggesting that the effects of PEEP and lowered 
Fio2 are additive. 
As was the case with Fio 2, the decreases in the 
Qp/Qs ratio that came from increasing PEEP ap- 
peared to be related to increases in pulmonary 
vascular esistance. This is seen in the middle panel 
of Fig. 5, where an increase in PEEP from 0 to 15 cm 
H20 led to an elevation in pulmonary vascular 
resistance from 118 _+ 13 to 297 +_ 17 dyne • sec/cm 
(p < 0.05). 
The lowerpanel of Fig. 5 shows the effect of PEEP 
on oxygen delivery. As was the case with lowering 
Fio2, increasing PEEP initially increased and then 
decreased oxygen delivery. 
Effect of supplemental carbon dioxide. Adding 
carbon dioxide to the ventilator circuit decreased 
the Qp/Qs ratio and increased pulmonary vascular 
resistance. High concentrations of supplemental 
carbon dioxide (Paco2 = 80 to 95 mm Hg, mean 
pH = 6.83 _+ 0.12) decreased the Qp/Qs ratio from 
1.33 _+ 0.11 to 0.42 + 0.12 when compared with a 
baseline of Fio 2 100% and PEEP 0 cm H20 (p < 
0.05). Pulmonary vascular esistance increased with 
carbon dioxide administration from 131 +_ 11 to 
432 _+ 81 dyne • sec/cm (p < 0.05). The decrease in 
the Qp/Qs ratio affected oxygen delivery, decreasing 
it from 99 _+ 15 to 68 _+ 11 ml/min (p < 0.05). 
Similar but greatly diminished effects were seen 
when concentrations of carbon dioxide similar to 
those used clinically were examined (Paco 2 = 50 to 
60 mm Hg, mean pH = 6.99 _+ 0.11). These 
concentrations of carbon dioxide lowered the Qp/Qs 
ratio from 1.33 + 11 to 1.25 + 0.31 (p = NS*), 
whereas pulmonary vascular resistance increased 
from 131 _+ 21 to 145 _+ 46 dyne • sec/cm (p = NS). 
The different results een with high and low concen- 
trations of carbon dioxide suggest that the effects of 
supplemental carbon dioxide are dose dependent. 
*NS = Not  s ign i f icant .  
Measurements of oxygen delivery. Fig. 6 contains 
individual data points from all experiments and 
interventions in this study. The upper panel shows 
the relationship of Sao 2 to oxygen delivery, and the 
lower panel plots the relationship of Svo 2 to oxygen 
delivery. Sao 2 appears to have a roughly linear 
relation to oxygen delivery at lower saturations but 
no correlation for higher saturations (r = 0.26, p = 
NS). The poor correlation between higher values of 
Sao 2 and oxygen delivery represents data taken at 
points with a Qp/Qs ratio greater than 1. At these 
values of Qp/Qs, oxygen delivery decreases as the 
Qp/Qs ratio increases, whereas Sao 2 remains ele- 
vated. 
The lowerpanel of Fig. 6 demonstrates the corre- 
lation between oxygen delivery and Svo2, higher 
levels of Svo 2 being associated with higher oxygen 
delivery (r = 0.81,p < 0.1). These data suggest hat 
Svo 2 provides a good estimate of oxygen delivery 
and that maximizing Svo 2 should maximize oxygen 
delivery. 
Discussion 
Background. Managing infants born with a uni- 
ventricular heart is a complex and challenging 
task. 11 Although newer, aggressive surgical ap- 
proaches now provide an alternative to the earlier 
policy of expectant management, overall survival is 
still l imited) 2The poor survival is at least partially 
caused by the marked hemodynamic instability that 
can characterize the clinical course of these infants. 
Improved medical management, then, should lead 
to better outcomes in this defect. 
Although clinical experience has shown that con- 
trolling the relative amounts of pulmonary flow and 
systemic flow is an important determinant of out- 
come, the physiologic basis of interventions de- 
signed to alter these flows has not been fully char- 
acterized. 13 We created an animal model of the  
univentricular heart in the hope that developing a
better understanding of this physiology could pro- 
vide the foundation for improved therapeutics) 
Our initial experiments focused on a number of 
respiratory interventions, inasmuch as these are a 
mainstay of present management techniques. We 
found that lowered Fio 2 decreased the Qp/Qs ratio, 
primarily by increasing pulmonary vascular resis- 
tance. Thus changing Fio 2 from 100% to 15% 
lowered the Qp/Qs ratio by 67% and increased 
pulmonary vascular resistance almost fourfold. 
PEEP had similar actions, with increased PEEP 
decreasing Qp/Qs ratio by 63% and increasing pul- 
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monary vascular esistance almost threefold. The 
effects of lowering Fio 2 and PEEP were additive, 
because PEEP added to the ventilator circuit at an 
Fio 2 of 21% decreased the Qp/Qs ratio further and 
increased pulmonary vascular resistance. Adding 
carbon dioxide to the breathing circuit also de- 
creased Qp/Qs and increased pulmonary vascular 
resistance. Different concentrations of carbon diox- 
ide had different magnitudes ofeffects on the Qp/Qs 
ratio and pulmonary vascular esistance, suggesting 
that carbon dioxide could be "titrated" for a desired 
change in Qp/Qs. 
Two other groups have used animal models of the 
univentricular circulation to examine the effects of 
ventilator changes, and their findings have been 
similar to ours. Mora and associates 14 studied a 
porcine model, created with cardiopulmonary b - 
pass and hypothermic circulatory arrest, which in- 
corporated a central shunt between the innominate 
and pulmonary arteries. They found that pulmonary 
vascular resistance increased as the concentration f 
carbon dioxide increased. Although the effects of 
carbon dioxide on the Qp/Qs ratio were not mea- 
sured directly, this study suggests that carbon diox- 
ide can be used to balance the Qp/Qs ratio and that 
it can be "titrated" for dose-dependent effects. 
Reddy and colleagues is used a model, constructed 
in fetal sheep, that was based on a Damus-Stansel- 
Kaye procedure. The effects of nitric oxide at 80 
ppm, 100% Fio 2, 10% Fio 2, and 5% carbon dioxide 
on the Qp/Qs ratio were examined. As in our study, 
lower Fi% and supplemental carbon dioxide de- 
creased the Qp/Qs ratio, whereas nitric oxide in- 
creased the Qp/Qs ratio. 
The present study went beyond simply delineating 
the effects of certain respiratory interventions on the 
Qp/Qs ratio, however, and examined the effects of 
these interventions on oxygen delivery. An earlier, 
computer-generated analysis of the univentricular 
circulation, which we 16 performed, suggested that a 
given intervention did not produce a constant 
change in oxygen delivery, but oxygen delivery was 
instead a function of the Qp/Qs ratio. This analysis 
suggested that the effects of therapeutics on oxygen 
delivery were determined by the Qp/Qs ratio at the 
time the manipulation was made. 
This study confirmed the predictions of our the- 
oretic analysis: although altering certain ventilator 
parameters could predictably change pulmonary 
vascular esistance and the Qp/Qs ratio, the result- 
ing changes in oxygen delivery were not consistent. 
We found that if the initial Qp/Qs ratio was high, a 
maneuver that lowered the ratio increased oxygen 
delivery, whereas for Qp/Qs ratios at or below 0.7, 
the same intervention decreased oxygen delivery 
(see bottom panel in Fig. 2 and in Fig. 3). These 
findings uggest that it may be necessary toobtain an 
estimate of the Qp/Qs ratio to predict he effect an 
intervention will have on oxygen delivery. 
In the preoperative state, where Qp/Qs ratios up 
to 4 are seen, interventions that lower the ratio are 
almost uniformly beneficial. After first-stage pallia- 
tion, however, Qp/Qs ratios are lower, ranging from 
0.5 to 1.5,17 and it is in this situation that lowering 
the Qp/Qs ratio may be detrimental. Although 
obtaining an estimate of the initial Qp/Qs ratio 
could potentially improve therapeutic decision mak- 
ing, in clinical practice directly measuring the ratio is 
difficult. Our study demonstrates that Sao 2 and Svo 2 
may be useful tools to estimate the Qp/Qs ratio. 
As seen in Figs. 3 and 4, there is a good correla- 
tion between the Qp/Qs ratio and both oxygen 
delivery and Sv02. As the Qp/Qs ratio increased, 
both oxygen delivery and Svo 2 initially increased; 
both then decreased as Qp/Qs went past an opti- 
mum range. The correlation between Svo 2 and 
oxygen delivery implies that interventions that in- 
crease Svo 2 increase oxygen delivery, thereby lead- 
ing to a more stable clinical situation. 
Although Sv02 is a useful predictor of oxygen 
delivery, it cannot yield a precise value for the 
Qp/Qs ratio. The reason is that the relation of Svo 2 
to the Qp/Qs ratio is two-tailed, so that a low value 
for Svo 2 may represent either a very high or very low 
Qp/Qs ratio. Our data show that the addition of 
Sa02 data to Sv02 measurements can provide a 
better estimate of the ratio. Because Sa% remains 
high even for "excessive" Qp/Qs ratios, a combina- 
tion of high Sao 2 and low Svo 2 represents a Qp/Qs 
ratio that is higher than optimal. Conversely, a low 
Svo 2 coupled with a low Sao 2 signifies a Qp/Qs ratio 
below optimum. When both Sao 2 and Svo 2 are high, 
a near optimal condition exists. 
The Sao 2 data alone cannot be used to estimate 
the Qp/Qs ratio, because it reaches a plateau for 
values of the ratio greater than 1. Thus, Sa% fails to 
distinguish between a Qp/Qs ratio of i or a ratio of 
3, even though one ratio is associated with clinical 
instability. This has been amply demonstrated in the 
clinical studies of Rossi and associates, 18 who re- 
ported a number of instances in which children with 
adequate Sao 2 readings had profound clinical insta- 
bility. Of note, in all of these cases clinical deterio- 
ration was preceded by a decline in Svo> 
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With the use of the framework derived from our 
model, Sao 2 and Sv02 measurements should be 
useful guides for therapy. Under this schema, when 
both Sao 2 and Sv02 are high, an optimum exists and 
no further interventions are necessary. High values 
of Sao 2 and low values of Svo2, seen with excessive 
Qp/Qs ratios, indicate that oxygen delivery could be 
increased by lowering the ratio, either by decreasing 
Fi02, or by adding PEEP to the ventilator circuit. 
Conversely, if pulmonary venous oxygen saturations 
and cardiac output are adequate and both Sao 2 and 
Sv02 are low, then the Qp/Qs ratio is too low, and 
lowering pulmonary vascular esistance, either by 
increasing Fio 2 or decreasing PEEP (if any is 
present in the ventilator circuit), would increase 
oxygen delivery. 
Limitations of the study. The major limitation of 
this model is the limited range of Qp/Qs produced. 
Even with an Fio 2 of 100% the mean Qp/Qs ratio 
was only 1.29, and the highest individual animal 
Qp/Qs was 1.79. This limitation occurred espite the 
use of a 6 mm innominate-pulmonary artery graft. 
The lack of a large pressure gradient across the graft 
suggests that species differences in pulmonary vas- 
culature, rather than technical difficulties in com- 
pleting the model, led to a limited Qp/Qs ratio. This 
limited range of Qp/Qs precludes us from determin- 
ing a value of Fio 2 that would result in an optimum 
Qp/Qs ratio in the human newborn infant. This 
limited range also likely explains why we found that 
oxygen delivery was maximal at an Fio 2 of 50%. 
Despite these limitations, this study still allows 
valuable conclusions to be drawn regarding the 
effects of a number of respiratory interventions on 
oxygen delivery. It also demonstrates the usefulness 
of monitoring Sao 2 and Svo 2 to guide therapeutic 
choices and assess outcomes. 
Conclusion 
New animal models of univentricular heart de- 
fects have provided the potential to examine the 
effects of different management strategies in a sys- 
tematic fashion. It is our hope that the creation of an 
armamentarium of therapeutics that can be admin- 
istered with predictable consequences will lead to 
improved survival for infants born with these de- 
fects. We believe that our study demonstrates the 
need to examine all potential therapeutics in the 
context of their effects on oxygen delivery. We hope 
that the schema we presented for using Sa02 and 
Svo 2 to estimate the Qp/Qs ratio will be a useful tool 
to choose therapies and assess their effectiveness. 
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